Tuesday, 7 April 2026
- Easy Return Policy: 10 Days Read More
- Best Selling Items: Up to 60% Off View More
- Delivery Method: All India Delivery (1.55 Lakhs Pincode) TC
- Customer Support: Raise 24*7 Quick Complaint
- Use Coupon: Get 50% Off (Follow us on Facebook). View Offers
- Save More: Up to 30% off on Shipping Above ₹559* View Offers
- COD: Subscription: Rs.999 Yearly!. T/C Apply
Frequently bought together
Biosimilars And Interchangeable Biologics: Strategic Elements | Niazi S K | 2nd Edition | Taylor & Francis Group (English Medium)
|
| 25287-25287 |
The second edition of "Biosimilars And Interchangeable Biologics: Strategic Elements" by Niazi S K is a comprehensive guide that provides insight into the strategic elements of biosimilars and interchangeable biologics. This book delves into the complex world of biosimilars, offering a detailed analysis of their development, regulation, and market access. With the increasing demand for affordable biologic therapies, biosimilars have emerged as a viable alternative to expensive branded biologics. This book explores the key strategic elements involved in the development and commercialization of biosimilars, including regulatory pathways, market dynamics, and intellectual property considerations. The author, Niazi S K, is an expert in the field of biosimilars and has extensive experience working with biopharmaceutical companies. In this second edition, he provides updated information on recent developments in the biosimilars industry, making it an essential resource for professionals working in this rapidly evolving field. Whether you are a researcher, healthcare professional, or industry stakeholder, "Biosimilars And Interchangeable Biologics: Strategic Elements" offers valuable insights that will help you navigate the complex landscape of biosimilar development and commercialization.
Biosimilars And Interchangeable Biologics: Strategic Elements (2nd Edition, 2026) by Niazi S K is a comprehensive and authoritative guide focused on the development, regulation, and commercialization of biosimilars and interchangeable biologics. Published by Taylor & Francis Group, this book is an essential resource for professionals in the biopharmaceutical industry, regulatory affairs, and advanced life sciences.
The book provides in-depth coverage of biosimilars, which are biologic medical products highly similar to already approved reference products. It explains the scientific principles behind biosimilarity, including analytical characterization, clinical evaluation, and regulatory pathways required for approval. The concept of interchangeability is also discussed in detail, highlighting how biosimilars can be substituted for original biologics in clinical practice.
This 2nd edition (2026) is updated with the latest global regulatory guidelines, including frameworks from major authorities such as the US FDA and EMA. It offers insights into evolving policies, intellectual property considerations, and market access strategies, making it highly relevant in today’s competitive pharmaceutical landscape.
The book also explores manufacturing challenges, quality control measures, pharmacovigilance, and risk management strategies associated with biosimilars. It emphasizes cost-effectiveness and accessibility, showcasing how biosimilars play a crucial role in reducing healthcare costs and improving patient access to life-saving biologic therapies.
With 258 pages of well-structured content, this hardbound edition is ideal for pharmaceutical scientists, regulatory professionals, healthcare policymakers, and postgraduate students specializing in biotechnology, pharmacy, and life sciences. The clear explanations, practical insights, and real-world examples make it both a learning resource and a professional reference.
Overall, this book serves as a valuable guide for understanding the complex yet rapidly growing field of biosimilars and interchangeable biologics, helping readers stay updated with current trends, regulatory expectations, and industry practices.
| SKU / BOOK Code: | BIO-NIAZI-2ED-2026-97810328699 |
| Publisher: | Taylor & Francis Group |
| Author: | Niazi S K |
| Binding Type: | Hardcover |
| No. of Pages: | 258 |
| ISBN-10: | NA |
| ISBN-13: | NA |
| Edition: | 2nd |
| Language: | English Medium |
| Publish Year: | 2026-01 |
| Weight (g): | 300 |
| Product Condition: | New |
| Reading Age: | Above 18 Years |
| Country of Origin: | India |
| Genre: | Science fiction |
| Manufacturer: | Taylor & Francis Group |
| Importer: | Taylor & Francis Group |
| Packer: | Fullfilled by Supplier |
The second edition of "Biosimilars And Interchangeable Biologics: Strategic Elements" by Niazi S K is a comprehensive guide that provides insight into the strategic elements of biosimilars and interchangeable biologics. This book delves into the complex world of biosimilars, offering a detailed analysis of their development, regulation, and market access. With the increasing demand for affordable biologic therapies, biosimilars have emerged as a viable alternative to expensive branded biologics. This book explores the key strategic elements involved in the development and commercialization of biosimilars, including regulatory pathways, market dynamics, and intellectual property considerations. The author, Niazi S K, is an expert in the field of biosimilars and has extensive experience working with biopharmaceutical companies. In this second edition, he provides updated information on recent developments in the biosimilars industry, making it an essential resource for professionals working in this rapidly evolving field. Whether you are a researcher, healthcare professional, or industry stakeholder, "Biosimilars And Interchangeable Biologics: Strategic Elements" offers valuable insights that will help you navigate the complex landscape of biosimilar development and commercialization.
Biosimilars And Interchangeable Biologics: Strategic Elements (2nd Edition, 2026) by Niazi S K is a comprehensive and authoritative guide focused on the development, regulation, and commercialization of biosimilars and interchangeable biologics. Published by Taylor & Francis Group, this book is an essential resource for professionals in the biopharmaceutical industry, regulatory affairs, and advanced life sciences.
The book provides in-depth coverage of biosimilars, which are biologic medical products highly similar to already approved reference products. It explains the scientific principles behind biosimilarity, including analytical characterization, clinical evaluation, and regulatory pathways required for approval. The concept of interchangeability is also discussed in detail, highlighting how biosimilars can be substituted for original biologics in clinical practice.
This 2nd edition (2026) is updated with the latest global regulatory guidelines, including frameworks from major authorities such as the US FDA and EMA. It offers insights into evolving policies, intellectual property considerations, and market access strategies, making it highly relevant in today’s competitive pharmaceutical landscape.
The book also explores manufacturing challenges, quality control measures, pharmacovigilance, and risk management strategies associated with biosimilars. It emphasizes cost-effectiveness and accessibility, showcasing how biosimilars play a crucial role in reducing healthcare costs and improving patient access to life-saving biologic therapies.
With 258 pages of well-structured content, this hardbound edition is ideal for pharmaceutical scientists, regulatory professionals, healthcare policymakers, and postgraduate students specializing in biotechnology, pharmacy, and life sciences. The clear explanations, practical insights, and real-world examples make it both a learning resource and a professional reference.
Overall, this book serves as a valuable guide for understanding the complex yet rapidly growing field of biosimilars and interchangeable biologics, helping readers stay updated with current trends, regulatory expectations, and industry practices.
We practice Easy Return / Exchange / Refund policy for Buyer Protection, So if you experience any difficulties like (Wrong Item delivered) with any of the product received, you can raise request under Return / Exchange Policy through the EXAM360 Customer support Portal i.e. https://support.exam360.in/ with valid details. Once our executive validate the case properly, we will take necessary steps as per the Policy Standard & we will be more than happy to help you to solve your issues ASAP.
While receiving the item from any of our courier partner, users are requested to check the packaging item properly, If you feel the item is delivering by the logistic partners in tampering conditions, we request our buyers not to accept the product & instantly make a call to the below mentioned HELPLINE Numbers. And, If you purchased an item that was not satisfactory, in such cases we will issue Return / Refund as per the current policy guidelines.
Selling Price & Shipping Fee: In Product details page we have clearly mentioned the Selling Price & Shipping Fees separately, So, when you click on "BUY NOW" You will be charges Selling Price + Shipping Fees. The Shipping fees may different for each products depends on the weight of the Product. The shipping cost includes the courier charges, packaging charges, transport charges, fuel charges and other charges. Sometimes the total payable amount may be different for Instamojo Payment Gateway. Buyers are requested to check before purchasing the products. After making the purchase we may not allow or consider users to modify.
- For more information about return policy CLICK HERE
- If you have questions about the product, please contact our dedicated Customer Support Team at ECG Portal.
Generally the courier partner support delivery during business hours (9:00 - 20:00) Mon - Sat: Fedex, Trackon, Gati, Delhivery, Indian Post.
The actual delivery time may differ from the given Estimated timeline. For more information on delivery time and shipping charges, please refer to our dedicated support team through ECG Portal.
Note: Expected Delivery time may differ from the Estimated or Projected delivery time & it does not include holidays.
.png)
.png)
.png)
.png)
.png)
.png)
No comments:
Post a Comment